# Naropin

NDC: 63323-286
Generic name: ROPIVACAINE HYDROCHLORIDE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, PERINEURAL
Marketing started: 20090804

FDA application: NDA020533

## Active ingredients

- ROPIVACAINE HYDROCHLORIDE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-286"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-286
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7